These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 11071300

  • 1. Vasopressin V1a receptor antagonism does not reverse adrenocorticotrophin-induced hypertension in the rat.
    Fraser TB, Turner SW, Wen C, Li M, Burrell LM, Whitworth JA.
    Clin Exp Pharmacol Physiol; 2000 Nov; 27(11):866-70. PubMed ID: 11071300
    [Abstract] [Full Text] [Related]

  • 2. L-arginine prevents corticotropin-induced increases in blood pressure in the rat.
    Turner SW, Wen C, Li M, Whitworth JA.
    Hypertension; 1996 Feb; 27(2):184-9. PubMed ID: 8567039
    [Abstract] [Full Text] [Related]

  • 3. Chronic vasopressin antagonism in two-kidney, one-clip renovascular hypertension.
    Burrell LM, Risvanis J, Phillips PA, Naitoh M, Johnston CI.
    Clin Exp Hypertens; 1997 Feb; 19(5-6):981-91. PubMed ID: 9247769
    [Abstract] [Full Text] [Related]

  • 4. Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat.
    Burrell LM, Phillips PA, Stephenson JM, Risvanis J, Rolls KA, Johnston CI.
    Hypertension; 1994 Jun; 23(6 Pt 1):737-43. PubMed ID: 8206571
    [Abstract] [Full Text] [Related]

  • 5. L-arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat.
    Wen C, Li M, Fraser T, Wang J, Turner SW, Whitworth JA.
    Blood Press; 2000 Jun; 9(5):298-304. PubMed ID: 11193135
    [Abstract] [Full Text] [Related]

  • 6. Adrenocorticotrophin dose-response relationships in the rat: haemodynamic, metabolic and hormonal effects.
    Turner SW, Wen C, Li M, Fraser TB, Whitworth JA.
    J Hypertens; 1998 May; 16(5):593-600. PubMed ID: 9797170
    [Abstract] [Full Text] [Related]

  • 7. Adrenocorticotrophic hormone-induced hypertension in the rat: effects of the endothelin antagonist bosentan.
    Fraser TB, Mangos GJ, Turner SW, Whitworth JA.
    Clin Exp Pharmacol Physiol; 1999 Aug; 26(8):628-33. PubMed ID: 10474778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands.
    Serradeil-Le Gal C, Wagnon J, Valette G, Garcia G, Pascal M, Maffrand JP, Le Fur G.
    Prog Brain Res; 2002 Aug; 139():197-210. PubMed ID: 12436936
    [Abstract] [Full Text] [Related]

  • 11. Circadian blood pressure variability in adrenocorticotrophin-induced hypertension in the rat.
    Turner SW, Fraser TB, Mangos GJ, Whitworth JA.
    J Hypertens; 2001 Aug; 19(8):1411-9. PubMed ID: 11518849
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of nitric oxide in adrenocorticotrophin-induced hypertension: L-arginine effects reversed by N-nitro-L-arginine.
    Wen C, Li M, Whitworth JA.
    Clin Exp Pharmacol Physiol; 2000 Nov; 27(11):887-90. PubMed ID: 11071304
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of NO synthesis has an additive effect on hypertension induced by ACTH in conscious rats.
    Li M, Dusting GJ, Whitworth JA.
    Clin Exp Pharmacol Physiol; 1992 Oct; 19(10):675-81. PubMed ID: 1330390
    [Abstract] [Full Text] [Related]

  • 16. Adrenocorticotrophin-induced hypertension in the rat: haemodynamic, metabolic and morphological characteristics.
    Whitworth JA, Hewitson TD, Ming L, Wilson RS, Scoggins BA, Wright RD, Kincaid-Smith P.
    J Hypertens; 1990 Jan; 8(1):27-36. PubMed ID: 2157753
    [Abstract] [Full Text] [Related]

  • 17. Effects of OPC-21268, a vasopressin V1-receptor antagonist, on expression of growth factors from glomeruli in spontaneously hypertensive rats.
    Otsuka F, Ogura T, Yamauchi T, Oishi T, Hashimoto M, Mimura Y, Makino H.
    Regul Pept; 1997 Oct 31; 72(2-3):87-95. PubMed ID: 9652981
    [Abstract] [Full Text] [Related]

  • 18. Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism.
    Burrell LM, Phillips PA, Risvanis J, Aldred KL, Hutchins AM, Johnston CI.
    Hypertension; 1995 Nov 31; 26(5):828-34. PubMed ID: 7591025
    [Abstract] [Full Text] [Related]

  • 19. Adrenocorticotrophin-induced hypertension in rats. Role of progesterone and digoxin-like substances.
    Li M, Wong KS, Martin A, Whitworth JA.
    Am J Hypertens; 1994 Jan 31; 7(1):59-68. PubMed ID: 8136112
    [Abstract] [Full Text] [Related]

  • 20. Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat.
    Burrell LM, Phillips PA, Risvanis J, Chan RK, Aldred KL, Johnston CI.
    Am J Physiol; 1998 Jul 31; 275(1):H176-82. PubMed ID: 9688911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.